Selective Inhibition of Growth of <i>Tuberous Sclerosis Complex 2</i>–Null Cells by Atorvastatin Is Associated with Impaired Rheb and Rho GTPase Function and Reduced mTOR/S6 Kinase Activity
Cancer research